Alumni/ae Class Notes

Joseph D. Gold, Ph.D., CDB, 1990-1991

jgold (at) geron.com

1990-1995----Post-doctoral fellow, laboratory of Radiobiology and Environmental Health, UCSF (laboratory of Dr. Roger Pedersen)
1996-present----Director, Geron Corporation

Bruce S. Kristal, Ph.D., Virology, 1990-1991

bkristal (at) partners.org

Academic:
12/1992-11/1993: Instructor, Department of Physiology, University of Texas Health Science Center at San Antonio (UTHSCSA)
12/1993-12/1996: Assistant Professor, Department of Physiology, University of Texas Health Science Center at San Antonio (UTHSCSA)
12/1996-4/2007: Research Scientist, Burke Medical Research Institute
6/1997-5/2004: Assistant Professor, Department of Biochemistry, Weill Medical College of Cornell University
10/1998-6/2006: Assistant Professor, Department of Neuroscience, Weill Medical College of Cornell University
7/2004-5/2007: Associate Professor, Department of Neuroscience, Weill Medical College of Cornell University
4/2007-present: Associate Professor, Department of Surgery, Harvard Medical School

Research:
Major Research Interests:
1. Mitochondrial involvement in neurologic injury/neuroprotection
2. Personalized disease risk prediction using metabolomics and proteomics
3. High data density informatics (-omics and clinical data)

Narrative Description of Research:

My laboratory currently has active projects in three areas: mitochondrial roles in neurologic injury, metabolomics and proteomics for personalized risk analysis, and the analysis of megavariate data sets.

There are no drugs currently available that protect the brains of people who have strokes, head injuries or neurodegenerative diseases, such as Alzheimer’s or Parkinson’s from further degeneration. We have identified a series of mitochondrially targeted, FDA-approved drugs that are being tested in a series of biochemical, cell and animal models. Initially we have examined over 1,000 different drugs and identified those that affect specific subcellular events believed to play roles in cell death caused by stroke, head injury, and neurodegeneration. These studies identified a series of drugs that delay the onset of neurodegeneration in both cell and animal models of stroke. Our data indicates that these drugs may lessen post-stroke damage and delay disease progression in humans. While other effects of these drugs must be considered, the fact that many of these agents are already in use suggests the potential to move these agents from “bench to bedside” with relative quickness. We have further developed analogs of these agents that may be more effective.

My laboratory is also testing whether blood tests based on studies of long-term food intake in rats can enable scientists to predict risk of human disease. Rats maintained on long-term, low calorie diets have reduced risk of certain diseases, such as cancer. This is analogous to the reduced risk of diseases seen in humans who are comparatively lean. My collaborators and I have developed approaches to simultaneously examine over 1,000 molecules in the blood. We then use mathematical approaches to identify sets of these compounds that can be used as dietary biomarkers (giving information about the diet). Our goal is to be able to use blood tests developed in these studies to predict long-term disease risk in individuals and use this information for possible protective interventions and increased monitoring. We are initially focused on diseases where preventative intervention and/or early diagnostic screening are available (eg, breast cancer, Type II diabetes).

We have also developed expertise in high data density informatics to support the medium- throughput studies we carry out on mitochondria and the high data density metabolomics studies that we are pursuing. As this side of our research has progressed, we are now turning the tools that we developed to address issues in clinical informatics, for example we are using these tools to understand the factors that modulate recovery (rehabilitation) following traumatic brain injury.

Michael D. Miller, Ph.D., Immunology, 1990-1991

Michael.Miller (at) gilead.com

Post Doctoral Fellow, Gladstone Institute of Virology and Immunology, 1992-1997
Research Scientist, Gilead Sciences, Inc., 1997-2000
Research Director, Gilead Sciences, Inc., 2001-2004
Senior Director, Gilead Sciences, Inc., 2004-present

Panos Papageorgiou, Ph.D., Physiology, 1990-1991

ppapageorgiou (at) bidmc.harvard.edu

Medical Internship, Residency, Cardiology & EP Fellowships at Beth Israel Hospital from 1990 to 1996. On staff at Beth Israel Deaconess Medical Center since 1996.

Michele S. Swanson, Ph.D., Genetics, 1990-1991

mswanson (at) umich.edu

Current position: Associate Professor, University of Michigan Medical School, Ann Arbor, MI.

Previous position: post doc, Tufts Medical School/HHMI, Department of Molecular Biology & Microbiology, Dr. Ralph Isberg.

Marja J. Van Zeijl, Ph.D., Anatomy, 1990-1991

vanzeim (at) wyeth.com

Post Doc at Lederle Labs, division of Amarican Cyanamid (now Wyeth), Pearl River, NY; 1991-1993
Research Scientist, Infectious Diseases Department, Wyeth, Pearl River, NY; 1993-2002
Pharmacologist, Hurley Consulting, Chatham, NJ; 2003
Director, Project Managament, Vaccines, Wyeth; 2003-present

Beth M. Weiner, Ph.D., BCMP, 1990-1991

bweiner (at) fas.harvard.edu

First postdoctoral fellow, now Research Associate at Harvard University.

David R. Wessner, Ph.D., Microbiology, 1990-1991

dawessner (at) davidson.edu

I have been at Davidson College since 1998. Currently, I teach courses in introductory biology, genetics, and microbiology. I also have been very involved in HIV/AIDS education. I teach an upper level seminar on HIV/AIDS and am developing a non-majors course on this topic. Much of my current research involves pedagogical research regarding HIV/AIDS education. Along with students, I have developed several web-based HIV/AIDS education resources and presented some of these resources at the most recent international AIDS conference.

John A. Assad, Ph.D., Neuroscience, 1991-1992

jassad (at) hms.harvard.edu

Current position: Associate Professor in Neurobiology, Harvard Medical School.

Previous position: Postdoc at Baylor College of Medicine, Houston, Texas.

Anthony N. Imbalzano, Ph.D., Microbiology, 1991-1992

Anthony.Imbalzano (at) umassmed.edu

--10/91-12/96---Post-Doctoral Fellow, Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School. Advisor: Robert E. Kingston. Recipient: 1/92-9/94 NRSA Post-Doctoral Fellowship; 9/94-9/96 US Army Medical Research Post-Doctoral Fellowship
-- 1/97-6/02---Assistant Professor, Department of Cell Biology, University of Massachusetts Medical School.
--5/98-present---Member, University of Massachusetts Cancer Center.
--7/99-6/04---Leukemia and Lymphoma Society (Leukemia Society of America) Scholar Award
--7/00-present---Member, University of Massachusetts Diabetes-Endocrine Research Center
--5/02-present---Director, Graduate Program in Molecular Cell Biology, Graduate School of Biomedical Sciences, University of Massachusetts Medical School.
--7/02-present---Associate Professor, Department of Cell Biology, University of Massachusetts Medical School
--11/02-9/03---Interim Director, Basic Sciences, Division of Leukemia and Lymphoma, University of Massachusetts Cancer Center
--5/05 – present---Vice-Chair, Department of Cell Biology, University of Massachusetts Medical School

Laurie Jackson-Grusby, Ph.D., Genetics, 1991-1992

laurie.jackson-grusby (at) childrens.harvard.edu

Current position: Assistant Professor of Pathology, Harvard Medical School.

Previous position: Postdoc at Whitehead Institute for Biomedical Research.

Emily R. Liman, Ph.D., Neuroscience, 1991-1992

liman (at) usc.edu

Post doc at Harvard with Linda Buck (1992-1994)
Post doc/Instructor at Harvard/MGH with David Corey (1994-1999)
Assistant Professor, University of Southern California (1999-2006)
Associate Professor, University of Southern California (2006-present)

Steven McIntire, M.D./Ph.D., Neuroscience, 1991-1992

slm (at) itsa.ucsf.edu

Residency in Neurology, University of Calofornia, San Francisco. Faculty member in Neurology, UCSF.

Laura J. Mundschau Kasman, Ph.D., Virology, 1991-1992

kasmanl (at) musc.edu

Post-doc fellowships at MIT, UC-Berkeley, and University of Georgia-Athens, though not in that order. Worked in industry for two years at Praecis Pharmaceuticals in Cambridge, MA (1993-1995). Took two years off from science (1996-1998) and successfully re-entered. Been at Medical University of South Carolina for 8 years.

Pamela F. Trotter, Ph.D., CDB, 1991-1992

pamtrotte (at) augustana.edu

1992-1996; Postdoctoral fellowship with Dennis R. Voelker Ph.D. at the National Jewish Center for Immunology and Respiratory Medicine in Denver, CO

1996-2001; Assistant Professor of Nutritional Sciences and Fellow in the Institute for Cellular and Molecular Biology at the University of Texas at Austin

2001-present; Department of Chemistry, Augustana College, Rock Island, IL

Dawn P. Wooley [Burns], Ph.D., Virology, 1991-1992

dawn.wooley (at) wright.edu

Postdoc with Nobel Laureate Howard Temin at the University of Wisconsin; Tenured Professor at Wright State University; Professionally certified in biological safety (Specialist Microbiologist in Biosafety, Registered and Certified Biosafety Professional); BSL-3 Laboratory Director.

Rebecca W. Heald, Ph.D., CMP, 1992-1993

heald (at) socrates.berkeley.edu

Post doc at EMBL Heidelberg: 1993-1997
Assistant Professor UC Berkeley: 1997-2003
Associate Professor UC Berkeley: 2003-2006
Professor UC Berkeley: 2006-present

Randall S. Johnson, Ph.D., Genetics, 1992-1993

rsjohnson (at) ucsd.edu

Post-doc at University of California, San Francisco, 1992-1995; Assistant Professor at University of California, San Diego, 1995-2001; Associate Professor at UCSD, 2001-2004; Professor at UCSD, 2004-present.

Janine M. Lasalle, Ph.D., Immunology, 1992-1993

jmlasalle (at) ucdavis.edu

1993-1996: Postdoctoral fellow, HHMI and Children's Hospital, Boston
1996-1997: Instructor of Pediatrics, Children's Hospital
1997-2003: Assistant Professor, Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, University of California, Davis
2003-2007: Associate Professor, Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, University of California, Davis
2007-present: Professor, Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, University of California, Davis

Su-Hao Lo, Ph.D., CDB, 1992-1993

shlo (at) ucdavis.edu

1994-1998---Postdoctoral fellow, Howard Hughes Medical Institute, Department of Molecular Genetics and Cell Biology, The University of Chicago, IL

1998-present---Assistant, Associate Professor, Center for Tissue Regeneration and Repair, School of Medicine, University of California, Davis

Pin Ouyang, Ph.D., Anatomy, 1992-1993

1992-1993, Postdoctoral research: Harvard Medical School
1993-present, Associate Professor of Anatomy: Chang Gung University, Taiwan
2000- present, Director of Laboratory Animal Center: Chang Gung University , Taiwan
2003- present, Director of Transgenic mice core-laboratory, Chang Gung University, Taiwan

Heike L. Pahl, Ph.D., Genetics, 1992-1993

pahl (at) sun2.ruf.uni-freiburg.de

1992 - 1995---Post-Doctoral Fellow, University of Munich and Freiburg, Germany
1995 - 1998---Instructor in Medicine, Univeristy of Freiburg
1998---Heisenberg Stipend
since 1998---Full Professor of Medicine, University of Freiburg

Ophelia Papoulas, Ph.D., CDB, 1992-1993

papoulas (at) mail.utexas.edu

Current position: Research Associate, University of Texas at Austin

Previous positions: Post-doc with Welcome Bender, HMS/DMS; Post-doc with Matthew P. Scott, Stanford University; Post-doc with John W. Tamkun, U.C. Santa Cruz

Elizabeth Ryder, Ph.D., Genetics, 1992-1993

ryder (at) wpi.edu

I was a post-doc for 3 years with Josh Kaplan at Mass General Hospital. I was first an Assistant Professor and am now an Associate Professor (tenured) at Worcester Polytechnic Institute since 1997.

Bruce C. Wightman, Ph.D., Genetics, 1992-1993

wightman (at) muhlenberg.edu

Postdoc at UC Berkeley in developmental neuroscience; currently in faculty position at Muhlenberg, a liberal arts college. I have served as contact for grad students and postdocs who are interested in pursuing careers as scientists in a liberal arts setting.

Kai Xia, Ph.D., Virology, 1992-1993

xiak (at) tmfhs.org

Residency and fellowship training at Brigham and Women's Hospital
Faculty (instructor) and attending at the Brigham and Women's Hospital
Chief and attending at the current institute: Trinity Mother Frances Health System, Tyler, Texas

David Altshuler, M.D./Ph.D., Genetics, 1993-1994

altshuler (at) molbio.mgh.harvard.edu

1993-1994 Completed medical school at Harvard
1994-1997 Clinical training in Internal Medicine and Endocrinology at Massachusetts General Hospital
1997-2000 Postdoctoral fellowship human genetics and genomics, Whitehead/MIT Center for Genome Research (mentor: Eric Lander)
2000-present Assistant and Associate Professor of Genetics and Medicine, Harvard and MGH
2003-present Founding Member, Director, Program in Medical and Population Genetics, Broad Institute of Harvard and MIT

Nai-Wen Chi, Ph.D., BCMP, 1993-1994

nwchi (at) ucsd.edu

Medical internship and residency and endocrine fellowship, MGH: 1994-1998
Postdoctoral fellowship, MIT: 1997-2000
Assistant Professor in Medicine, University of California, San Diego: 2000-present

Michael J. Fath, Ph.D., Microbiology, 1993-1994

michael.fath (at) abbott.com

1993-1995: Post-doctoral research fellow - Molecular Genetics and Cell Biology - The University of Chicago - molecular genetics on Anabaena development
1995-1998: Management consultant - McKinsey & Co., Inc., Chicago, IL
1998-present: various positions at Abbott Laboratories including Strategic Planning, Business Development, New Product Planning, Medical Marketing, and Clinical Science

William C. Hahn, M.D./Ph.D., Immunology, 1993-1994

William_Hahn (at) dfci.harvard.edu

Current position: Associate Professor of Medicine, Harvard Medical School

Previous positions: Residency – Internal Medicine – MGH; Fellowship – Medical Oncology – DFCI; Postdoc – Bob Weinberg, Whitehead Institute

Susan M. Michaud, Ph.D., CDB, 1993-1994

michaud (at) clarkelbing.com

Technology Specialist/Patent Agent, Fish & Richardson PC, Boston, MA 02110 (1993-1997)
Patent Agent/Associate/Partner, Clark & Elbing LLP, Boston, MA 02110 (1997-present)

Jared A. Silverman, Ph.D., Microbiology, 1993-1994

jared.silverman (at) cubist.com

4 year postdoc at Yale Medical School studying the intracellular parasite toxoplasma; nearly 10 years (6/97) at Cubist working on antibiotic discovery and development.

Yang Xu, Ph.D., Immunology, 1993-1994

yangxu (at) ucsd.edu

1994-1997, Postdoc at MIT
1997-present, Faculty at University of California, San Diego

Kathryn D. Curtin, Ph.D., Virology, 1994-1995

kcurtin (at) uark.edu

Previously Post Doc, Yale University (1995-2003); currently Assistant Professor, University of Arkansas (2003-present).

David A. Fruman, Ph.D., Immunology, 1994-1995

dfruman (at) uci.edu

1) Postdoc at Harvard Medical School, Dept. of Cell Biology, mentor: Lewis Cantley (1995-1999)
2) Postdoc at UCLA, Howard Hughes Medical Institute, mentor: Owen Witte (1999-2000)
3) Assistant Professor, University of California, Irvine (2000-2005)
4) Associate Professor with tenure, UC Irvine (2005-present)
5) Visiting Scientist (sabbatical), Institut Cochin, Paris, France (2006-2007)

Amy Wheeler Hudson, Ph.D., CDB, 1994-1995

ahudson (at) mcw.edu

Current position: Assistant Professor, Medical College of Wisconsin, Milwaukee, WI

Previous positions: NSF/JISTEC Summer Institute in Japan (1995); Postdoc, lab of Pietro DeCamilli, Dept. of Cell Biology, Yale University School of Medicine; Postdoc, labs of Peter Howley, Dept. of Pathology, Harvard Medical School, and Hidde Ploegh, Dept. of Pathology, Harvard Medical School

Jeng-Shin Lee, Ph.D., Virology, 1994-1995

jlee (at) receptor.med.harvard.edu

I am the Deputy Director of Harvard Gene Therapy Initiative, an organization founded in 1998 within Harvard Medical School with the objective of promoting the use of gene transfer technology in both research and therapeutic applications. Over the last nine years, my group has been primarily responsible for the development of three cell based products intended for cancer immunotherapy, the development of both research and clinical grade production of adeno-associated viral vectors targeting neuromuscular systems, as well as newer generation lentiviral vector systems. The work has supported two approved investigational new drug (IND) applications in the United States and Europe, and several more in progress, in collaboration with physician scientists at Dana Farber Cancer Institute and elsewhere.

Before joining Harvard Gene Therapy Initiative in 1999, I received post-doctoral training at Whitehead Institute, MIT, and Children’s Hospital, Boston. Prior to receiving my PhD in Virology in 1995, I received my MD from National Taiwan University in 1990.

Vivian Fan Liu, Ph.D., Microbiology, 1994-1995

vliu (at) alum.mit.edu

1. Postdoctoral fellowship at Stanford University, Dept of Pathology, Dr. Teresa S.-F. Wang's lab (1995-2000)
2. Signature Bioscience (Senior Scientist) from 2000-2003
3. MDS Sciex (Senior Scientist) from 2003-2005
4. Consulting (2005-current)

Cynthia (Cindy) K. Miranti, Ph.D., BCMP, 1994-1995

cindy.miranti (at) vai.org

Current position:Principal Scientific Investigator & Assistant Professor, Van Andel Research Institute, Grand Rapids, MI.

Previous position: Post doctoral fellow in Joan Brugge’s lab (HMS) for 5 years.

Robert L. Morris, Ph.D., CDB, 1994-1995

rmorris (at) wheatonma.edu

Previously did a Post-doc in the Lab of Jonathan Scholey, University of California, Davis. Currently Tenured faculty member at Wheaton College in Norton, MA. Teaching Developmental Biology, Cell Biology, Intro Cell and Molecular Biology, Neurobiology, Advanced Marine Biology. Most recent published research is on cytoskeletal and motor proteins in sea urchin embryogenesis and ciliogenesis by microscopic and genomic approaches.

Ramon Rivera-Gonzalez, Ph.D., Microbiology, 1994-1995

rriverag (at) amgen.com

1995 - 1996: Postdoctoral Fellow, Pfizer Central Research
1996 - 1999: Postdoctoral Fellow, Dana-Farber Cancer Institute
1999 - 2000: Senior Scientist, Abbott Diagnostics
2000 - present: Quality Analytical Laboratory Specialist, Manager Compliance, Senior Manager Compliance, Senior Manager Compliance, Associate Director Compliance, Director Quality Assurance, Amgen Inc.

Victor I. Shifrin, Ph.D., CDB, 1994-1995

vshifrin (at) DrugDiscoverySolutions.com

1995: Postdoctoral Fellow, Dana-Farber Cancer Institute
1998: Senior Scientist II, Virology, Scriptgen Pharmaceuticals
2000: Scientist, Anticancer Biology, Acting Associate Director, Screening Technology, Eisai Research Institute
2003: Principal Research Investigator, Head of Discovery Biology, Director of Pharmacology, Surface Logix
2005: Team Leader, Discovery Biology, CombinatoRx
2007-Present: Consultant, Assay Development and Outsourcing, Drug Discovery Solutions

Eric J. Brown, Ph.D., Immunology, 1995-1996

brownej (at) mail.med.upenn.edu

Assistant Professor of Cancer Biology (University of Pennsylvania, 2003 to present)
----My laboratory studies how DNA damage response genes maintain genome stability to suppress cancer and other age-associated disorders. Previous research has shown that the ATR protein kinase mediates a signaling pathway that prevents double strand break formation in the event that DNA replication stalls. Since DNA replication stalling occurs in every cell cycle at sites of normal oxidative DNA damage, failure of the ATR-mediated pathway to function properly at these sites may be a major source of genomic instability that causes cancer and age-related diseases.

Postdoctoral research with Prof. David Baltimore (M.I.T. and Caltech, 1996 to 2003)
----Generated two mouse models that disrupt the ATR checkpoint kinase and studied the effects of deletion on cell cycle checkpoints, checkpoint signaling, genome stability, embryonic development, and tumorigensis. ATR is required for genome maintenance and tumor suppression. Cre/lox conditional deletion of ATR leads to loss of cell cycle checkpoints and genome stability during S phase.

Hwai-Jong Cheng, Ph.D., CDB, 1995-1996

hjcheng (at) ucdavis.edu

1996-1997---Medical Resident, Pathology, National Taiwan University Hospital, Taipei, Taiwan
1997-2002---Postdoctoral Fellow, Dr. Marc Tessier-Lavigne, Howard Hughes Medical Institute, Department of Anatomy, University of California at San Francisco, and Department of Biological Sciences, Stanford University
2002-presesnt---Assistant Professor, Center for Neuroscience, University of California, Davis

John W. Donovan, Ph.D., Microbiology, 1995-1996

jdonovan (at) mpi.com

I did a Post Doc at the Dana Farber Cancer Center with John Gribben, MD, PhD. Here I developed and improved methods for detecting residual disease in leukemia and lymphoma as well as investigated the potential use of data from these assays in making treatment decisions for patients undergoing chemotherapy.

I joined Millennium in 2000 as a Scientist in their Process Technology group where I provided assay development, automation and process improvement support for the Discovery organization. I am now a member of their Lead Discovery group where I head the automation group. We provide automation support for high throughput screening and other assays that support early drug discovery. In addition to this role I also interact with Scientist across the company to help develop automation friendly assays.

David P. Frazier, Ph.D., Microbiology, 1995-1996

david.frazier (at) finnegan.com

After completing the Ph.D. program at DMS, I attended law school at Georgetown University Law Center while working full time for a patent law firm. I continued with the same firm after graduation and became a partner in the firm. My current legal practice involves primarily patent litigation and prelitigation counseling as well as intellectual property due diligence investigations in the area of pharmaceuticals, biologics, and life science diagnostics.

Robert M. Freeman, Ph.D., Virology, 1995-1996

bob_freeman (at) hms.harvard.edu

After graduating from the DMS Virology program, I worked for two years with the Department of Cell Biology at Harvard Medical School as their scientific IT systems manager, working with labs to more effectively utilize IT in their research. In 1997, I was appointed Director of the Research Computing Center, an HMS-wide department which provided research application support, training, and in-house consultation. In 2002, I left HMS to join a technology consulting company, and worked at Biogen Idec, Inc. of Cambridge, MA. During this time I started a small company to provide technology integration and computational biology research services. In 2004, I rejoined HMS as a part-time scientist.

I am currently a staff scientist in Mark Kircshner's lab in the Department of Systems Biology at Harvard Medical School, part of a multi-geographic team working on the hemichordate Saccoglossus kowalevskii (common name, the Acorn worm). As a means to understanding the evolution of chordates and the early bilateral ancestor, we are studying the expression of key genes and developmental circuits in early development through EST sequencing, in situs, and microarrays.

The usual lab work schedule is pleasantly interrupted each year in September, at which time we relocate to the Marine Biology Labs in Woods Hole, MA to work with live animals. Designated a model organism by the NIH, the genome is currently being sequenced and we hope to have the full assembly by the end of 2007. My responsibilities are a) analyzing and managing all the sequence and expression data for the project team, b) to design and deploy visualization tools, c) lead person for the microarray design and analysis, and d) lead team member for the logistics for the genome annotation.

Vishwanath R. Iyer, Ph.D., Genetics, 1995-1996

vishyiyer (at) gmail.com

After getting my Ph.D in Genetics working in Kevin Struhl's lab in BCMP, I went to Stanford University as a postdoctoral fellow in the lab of Pat Brown in the Biochemistry Department. I joined UT Austin as an assistant professor in 2000.

Georg Jander, Ph.D., Microbiology, 1995-1996

gj32 (at) cornell.edu

2 years postdoc at Massachusetts General Hospital, 4 years scientist at the Monsanto Company, 5 years Assistant Scientist at the Boyce Thompson Institute and Adjunct Assistant Professor at Cornell University.

Jae Keith Joung, M.D./Ph.D., Genetics, 1995-1996

jjoung (at) partners.org

Clinical Fellow in Pathology (Resident in Clinical Pathology), Massachusetts General Hospital (1996-1999)
Research Fellow in Pathology, Massachusetts General Hospital (1999-2000)
Post-doctoral Fellow, Department of Biology, Massachusetts Institute of Technology (1998-2001)
Instructor in Pathology, Harvard Medical School (2000-2004)
Assistant Professor of Pathology, Harvard Medical School (2004-present)
Assistant Pathologist, Massachusetts General Hospital (2000-present)
Director, Molecular Pathology Unit, Massachusetts General Hospital (2007-present)

Jae Bum Kim, Ph.D., Microbiology, 1995-1996

jaebkim (at) snu.ac.kr

Previously worked at Center for Cancer Research, MIT; currently Associate Professor at Seoul National University.

Roger B. Knowles, Ph.D., Neuroscience, 1995-1996

rknowles (at) drew.edu

2003-present---Associate Professor, Department of Biology, Director of Neuroscience Program at Drew University
1998-2003---Assistant Professor, Department of Biology, Director of Neuroscience Program at Drew University
1996-1998---Postdoctoral Research Fellow, Department of Neurology, Alzheimer's Research Center, Massachusetts General Hospital, Harvard University

Jie-Oh Lee, Ph.D., BCMP, 1995-1996

jieoh.lee (at) kaist.ac.kr

(1) Postdoc, 1996~2000, Memorial Sloan Kettering Cancer Center
(2) Assistant Professor, 2000~2001, University of Maryland Baltimore County
(3) Assistant & Associate Professor, 2001~present, Korea Advanced Institute of Science and Technology

Christine A. Lekutis, Ph.D., Immunology, 1995-1996

clekutis (at) mofo.com

1997-2001: Postdoc in Dept. of Microbiology and Immunology, Stanford University School of Medicine
2001-2008: Technology Specialist and Patent Agent, Medlen & Carroll, LLP
2008-present: Patent Agent, Morrison & Foerster, LLP

Christa S. Merzdorf, Ph.D., CDB, 1995-1996

merzdorf (at) montana.edu

After receiving my degree, I finished work in my thesis lab. Then I joined Hazel Sive's laboratory at the Whitehead for a postdoc position since I was very interested in getting back into developmental biology. My research focused on the molecular basis of early neural development in the frog Xenopus. My husband and I were out of phase so that I became a trailing spouse, leaving my postdoc position prematurely to move to Bozeman and begin a research track position at Montana State University (I also had my three children during this time). I was able to obtain a tenure track position at Montana State University in 2002. The work in my laboratory focuses on the molecular networks that govern early neural development in Xenopus and chick embyros.

George Todd Milne, Ph.D., Microbiology, 1995-1996

tmilne (at) microbia.com

Postdoctoral Fellow with Gerry Fink, Whitehead Institute, 1996-1998
Microbia, 1998-present

Keith Solomon, Ph.D., Immunology, 1995-1996

keith.solomon (at) childrens.harvard.edu

1996-1997---Research Fellow, laboratory of Dr. Robert Finberg, Harvard University/DFCI
1997-1998---Research Fellow, laboratory of Dr. Jan Schnitzer, Harvard University/BIDMC
1998-2002---Instructor, Orthopedic Surgery, Harvard Medical School/Research Associate, Orthopedic Surgery, Children’s Hospital Boston
2002-present---Assistant Professor, Orthopedic Surgery, Harvard Medical School/Research Associate, Orthopedic Surgery, Children’s Hospital Boston
2003-present---Ad Hoc member of NCI-I, Study Section
2004-present---Ad Hoc member of Tumor Cell Biology (TCB), NIH Study Section
2004-present---Administrative Director of the Children’s Hospital Proteomics Center
2004-present---Associate in Urology, Children’s Hospital Boston
2005-present---Ad Hoc member of UKGD, NIH Study Section
2005-present---Chair, Children’s Hospital Data Protection Work Group

Martha C. Soto, Ph.D., Genetics, 1995-1996

sotomc (at) umdnj.edu

Congressional Science Fellow, ASM (American Society for Microbiology) 1995-1996, Legislative Assistant to Rep. Jim McDermot (D-WA). Worked on legislation to protect the privacy of genetic information, etc.

Postdoctoral Fellow, Laboratory of Craig Mello, U. Mass. Medical Center, Worcester MA, 1997-2002.

Faculty, Pathology Dept., Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 2003- present.

Willem J. Van Heeckeren, Ph.D., Genetics, 1995-1996

wvanheeckeren (at) yahoo.com

Post-doc at the University of Oregon researching maize a3 mediation of anthocyanin transcriptional regulation in the laboratory of Vicki Chandler.

Post-doc at Case Western Reserve University School of Medicine researching alternative mRNA splicing regulation in the fission yeast schizosaccharomyces pombe in the laboratory of Jo Ann Wise.

Medical School at Case Western Reserve University School of Medicine.

Internship/Residency in Internal Medicine at University Hospitals of Cleveland.

Current: Fellowship in Hematology/Oncology at University Hospitals of Cleveland.

Kristina (Wietasch) Becker, Ph.D., Neuroscience, 1996-1997

Kristina.Becker (at) biochem.uni-erlangen.de

Currently Group Leader, Institute of Biochemistry, University of Erlangen, Germany. Training as an Anesthesiologist; Postdoctoral training Biochemistry, focus Neuroscience.

Ana M. Borras, Ph.D., Virology, 1996-1997

ana_borras (at) dfci.harvard.edu

Senior Research Scientist, Translational Research Lab (Director: Robert J. Distel, PhD), Dana-Farber Cancer Institute, Boston, MA (2004-present)
--Established a DHPLC-based platform to screen for mutations that correlate with drug response and resistance to Tyrosine Kinsase inhibitor in lung cancer.
--Developed an assay to detect mutations in circulating tumor cells.
--Established a FACS assay to detect circulating endothelial cells in peripheral blood of cancer patients undergoing anti-angiogenic treatment.
--Collaborate with clinicians and industry partners.

Research Fellow (part-time membership), Harvard AIDS Institute (Supervisor: Richard Marlink, MD), Harvard School of Public Health, Boston MA (2003)
--Researched and helped write clinical research proposals aimed at monitoring AIDS treatment in Botswana.

Scientist, Discovery Research Group (Supervisor: Isaac Rondon, PhD), Dyax Corp., Cambridge, MA (2000-2002)
--Developed antibody and peptide therapeutic candidates for the treatment of inflammatory disease and pain.
--Employed phage display libraries expressing Fabs or peptides.
--Project Leader - designed and executed research projects: cloned, expressed and produced the target molecule, selected candidates against target, developed assays to identify lead candidates for pre-clinical studies, and produced human antibody version of lead candidates.

Postdoctoral Research Fellow, Dept. of Medicine/Gerontology, Lab of Jeanne Wei, MD/PhD, Harvard University/Beth Israel Deaconess Medical Center, Boston, MA (1999-2000)
--Researched the molecular response of cardiac cells to oxidative stress. Specifically, the activation of the JAK/STAT pathway in primary cardiac cells and established cell lines.
--Collaborated on study of transgenic mice overexpressing serum response factor.
--High throughput screening of gene expression profiles in caloric restricted vs. normal mice.

Postdoctoral Research Fellow, Dept. of Medicine/Gerontology, Lab of Sam Lee, PhD, Harvard University/Beth Israel Deaconess Medical Center, Boston, MA (1997-1998)
--Investigated the cell cycle of normal mammary epithelial cell vs. that in cancerous cell lines. Specifically, researched the role of cyclin G, BRCA1 and PCNA in breast cancer.

Zahra Diala Ezzeddine, Ph.D., Genetics, 1996-1997

ezzeddine (at) verizon.net

1997-1998----American University of Beirut (Beirut, Lebanon): Post-doctoral fellowship from the Mellon Foundation to organize a conference on Science, Technology and Society (took place in Nov. 1998)
Summer 1998----Vertex Pharmaceuticals (Cambridge, MA): internship in R&D Planning
1999 – 2004----Millennium Pharmaceuticals, Inc. (Cambridge, MA): business development
2004 - 2008----HydroSpine, Inc. (Boston, MA): CEO
2008 - present----Biotech business development consultant, Boston, MA

Seth Field, M.D./Ph.D., Genetics, 1996-1997

sjfield (at) ucsd.edu

Internship and Residency in Internal Medicine at the Hospital of the University of Pennsylvania, 1997-1999
Fellowship in Endocrinology at the Massachusetts General Hospital, 1999-2001
Post-doctoral Fellowship with Lewis Cantley, Professor of Cell Biology/Systems Biology, Harvard Medical School, 2000-2005
Instructor in Medicine, Harvard Medical School, 2002-2005
Assistant Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, 2005-present. My lab is studying the functions of phosphoinositides.

Wedny Hanna-Rose, Ph.D., Microbiology, 1996-1997

wxh21 (at) psu.edu

Current position: Assistant Professor at Penn State University, University Park, PA

Previous position: Postdoctoral fellow at University of Colorado, Boulder in Department of Molecular, Cellular and Developmental Biology

Chrystal Ho Pao, Ph.D., Genetics, 1996-1997

chopao (at) tiu.edu

Postdoctoral research at MIT (1997 - '98)
Assistant Professor at Trinity International University (1998 - 2001)
Homemaker (2001- 06)
Assistant Professor at Trinity International University (2006 - 07)

Sara Whitney Lazar, Ph.D., Microbiology, 1996-1997

lazar (at) nmr.mgh.harvard.edu

Current position:Assistant Professor in Psychology at MGH

Previous positions: Postdoc and Assistant Professor at MGH in Psychiatric Neuroimaging.

Kay Lee-Fruman, Ph.D., Immunology, 1996-1997

kleefrum (at) csulb.edu 

Postdoc for 2 years at Harvard Medical School, then the current faculty position of Associate Professor at California State University, Long Beach, CA.

My position is a 50:50 split of research and teaching, and I love it. If you are interested in knowing more about teaching-oriented faculty positions with less pressure on research, I'd be happy to help.

Stephen L. Macknik, Ph.D., Neuroscience, 1996-1997

macknick (at) neuralcorrelate.com

I postdoc’d with David Hubel at HMS, and also with Zach Mainen at Cold Spring Harbor Lab. I got my first faculty position at University College London in 2001, before moving to my current laboratory at the Barrow Naeurological Institute (Phoenix, AZ) in 2004.

Jon M. Madison, Ph.D., Genetics, 1996-1997

madison (at) molbio.mgh.harvard.edu

In a post-doc with Josh Kaplan at UC Berkeley and Harvard/MGH. Developed in situ electrophysiological techniques to record synapse function in C. elegans. Subsequently, studied regulation of synapse and circuit function by microRNAs and synaptic proteins using electrophysiology and molecular genetics.

Martin Myers, Ph.D., CDB, 1996-1997

mgmyers (at) umich.edu

Instructor then Assistant Professor at HMS/Joslin Diabetes Center. Moved to the University of Michigan in 2004. Currently researching leptin receptor signaling and the molecular and neural mechanisms of leptin action in body energy homeostasis.

Craig Nelson, Ph.D., Genetics, 1996-1997

Craig.Nelson (at) uconn.edu

Current position: Faculty, University of Connecticut

Previous position: Postdoctoral Fellow, University of Wisconsin-Madison with Sean Carroll

Gustavo Rafael Rosania, Ph.D., CDB, 1996-1997

grosania (at) umich.edu

PostDoc with Peter G. Schultz at the Chemistry Department at University of California, Berkeley (1997-1999)

Research Scientist at Cellomics, Inc. (now Thermo-Fisher) in Pittsburgh, PA (1999-2001)

Assistant Professor at the University of Michigan (2001-present)

Laura Rosen, Ph.D., CDB, 1996-1997

laura_rosen (at) merck.com

Neurology Residency, University of Chicago Hospitals: 1997-2001
Post-doc with Dennis Selkoe, Center for Neurologic Diseases, Brigham and Women's: 2001-2003
Associate Director, Clinical Pharmacology, Merck: 2003-2005
Director, Clinical Pharmacology, Merck: 2005-present

Adopted our daughter Jillian LiJia from Hubei, China: 2003 (now 4 years old)

Allison (Koweek) Schnipper, Ph.D., Genetics, 1996-1997

allisonschnipper (at) hotmail.com

I worked for 2.5 years as an administrator at St. Mary's Women and Children's Center, a shelter in Dorchester. In 2000, I started my own business, Professional Organizing Services. I help people organize their homes and offices. I work part-time, and I am home with my two children the rest of the time.

Chi-Chang K. Shieh, Ph.D., Immunology, 1996-1997

cshieh (at) mail.ncku.edu.tw

After my graduation, I returned to Taiwan after a short fellowship at HMS. I have worked as a attending pediatrician at National Cheng Kung University Medical College (Tainan, Taiwan) ever since. I take care of children with immunological diseases (allergy, autoimmunity and immunodeficiency) and, at the same time, teach under- and post-graduate students.

My current interests in research include the immune dysregulations caused by gene mutations and effects of redox modification on integrin-mediated leukocyte binding.

Karin E. Sorra, Ph.D., Neuroscience, 1996-1997

ksorra (at) arroscience.com

10+ years experience in bio/pharmaceutical medical marketing, research and development. Currently President and Chief Scientific Officer at Arroscience Inc., Toronto, Ontario, Canada.

Ben Stanger, M.D./Ph.D., Genetics, 1996-1997

bstanger (at) mail.med.upenn.edu

Current position:Assistant Professor, University of Pennsylvania, Philadelphia, PA.

Previous positions: Residency training in Internal Medicine, Fellowship in Gastroenterology, Research fellowship in Developmental Biology (advisor: Doug Melton).

Wendy Weiger, M.D./Ph.D., Neuroscience, 1996-1997

wendy_weiger (at) achormaine.com

Internship in internal medicine at BU Medical Center (I received an MD/PhD degree) followed by a research fellowship at Harvard Medical School's Osher Institute (primary project: scientific review of complementary/alternative therapies commonly used by patients with cancer). In late 2003, I moved to Maine, where I now work as an independent writer and environmental activist.

Gregory Zinkl, Ph.D., CDB, 1996-1997

gzinkl (at) dykema.com

Post doctoral Fellow, University of Chicago, Laboratory of Daphne Preuss (1997-2000)
Scientific Advisor/Patent Agent - Brinks Hofer Gilson & Lione PC (2000-2002)
Scientific Advisor/Patent Agent - Sonnenschein Nath & Rosenthal LLP (2002-2004)
Scientific Advisor/Patent Agent - Dykema Gossett PLLC (2004-2007)
Associate Attorney - Dykema Gossett PLLC (2007-present)
Chicago-Kent College of Law (Illinois Institute of Technology) J.D. 2007

Allison Joy (Oppenheimer) Berger, Ph.D., Genetics, 1997-1998

aberger (at) mpi.com

1998-2000: Postdoctoral fellow, Millennium Predictive Medicine
Worked on transcriptional profiling of cervical cancer and precancerous lesions to aid development of a diagnostic test for cervical cancer

2000-2002: Scientist, Millennium Predictive Medicine
Worked on transcriptional profiling of colon cancer and normal colon specimens to develop a diagnostic test for colon cancer

2003-present: Scientist, Millennium Pharmaceuticals
As part of the Oncology Discovery group, developed pharmacodynamic biomarkers for preclinical and clinical use in evaluating several drug candidates.

Laura T. (Smith) Bortolin, Ph.D., CDB, 1997-1998

bortolin (at) ll.mit.edu

I have worked at MIT Lincoln Laboratory since my graduation, researching biowarfare defense technologies.

Jennifer R. Brown, M.D./Ph.D., Program, 1997-1998

jbrown (at) partners.org

Finished medical school, residency and oncology fellowship; now clinical/translational faculty at Dana-Farber Cancer Institute with particularly interest in unraveling the heritability of lymphoma/CLL.

Lynne Garrity-Ryan, Ph.D., Microbiology, 1997-1998

lgarrity-ryan (at) paratekpharm.com

Previously in postdoctoral Research at the University of California, San Francisco in the laboratory of Joanne N. Engel.

Began employment at Paratek as Scientist I in 2002.

Lisa M. Genova, Ph.D., Neuroscience, 1997-1998

lisa (at) lisagenova.com

Author of the acclaimed novel, STILL ALICE, and Blogger for the National Alzheimer's Association.
www.StillAlice.com
www.actionalz.org

James R. Gorman, M.D./Ph.D., Immunology, 1997-1998

gorman (at) post.harvard.edu

I currently serve as President of BioAssets Development Corporation (BDC), a biopharmaceutical company that is pursuing development of novel drug therapies to treat spinal disorders and pain that has traditionally been treated with disk and spine surgery or devices. Prior to founding BDC, I spent seven years in licensing and strategic initiatives at Abbott Laboratories, where I was responsible for identifying, recommending and coordinating the strategy to grow Abbott’s biologics business. In 2002, I received an Abbott President’s Award for my role in initiating, championing and executing the acquisition of the blockbuster anti-TNF antibody Humira® and the cutting-edge biologics platform resulting from Abbott’s $7 billion acquisition of BASF Pharmaceuticals in 2001. Immediately after graduation in 1997, I trained for one year in pediatrics at Children’s Hospital of Boston.

Robin Jackman, Ph.D., Immunology, 1997-1998

1998-2002, Worked on Wall Street as an investment banker raising money for biotechnology companies.
2002-present, working in business and corporate development for several biotechnology companies on the deal/business origination/collaboration side; currently head of oncology division running a Phase 3 pivotal trial with a novel immunotherapeutic drug for cancer.

Helene M. Puccio, Ph.D., Genetics, 1997-1998

hpuccio (at) igbmc.u-strasbg.fr

Current position: Permanent research position from French government INSERM since 2001, at the Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC).

Previous position: Postdoctoral fellowship at IGBMC, France.

Kirsten C. Sadler Edepli, Ph.D., CDB, 1997-1998

kirsten.edepli (at) mssm.edu

Assistant Professor, Bosphorus University, Istanbul, Turkey: 1998-2001
Postdoctoral Fellow, MIT, Center for Cancer Research, Hopkins' laboratory: 2002-2005
Assistant Professor, Mount Sinai School of Medicine, New York, NY: 2005-present

Maurice G. Sholas, M.D./Ph.D., Neuroscience, 1997-1998

msholas (at) lsuhsc.edu

I completed Residency Training in Physical Medicine and Rehabilitation at the University of Texas Health Science Center – San Antonio. Then I did a Fellowship in Pediatric Rehabilitation Medicine at the Rehabilitation Institute of Chicago. I was the first Board Certified physician in Pediatric Rehabilitation Medicine in the State of Louisiana. I recently held the position of Director of the Pediatric PM&R Program, while actively pursuing clinical research as an Assistant Professor. I am now Medical and Practice Director for Rehabilitation Services at Children’s Healthcare of Atlanta.

Lisa A. Stevens, Ph.D., Program, 1997-1998

lisa_stevens_winkler (at) yahoo.com

Current position: Parenting

Previous position: Postdoctoral fellow, University of Washington, Seattle, WA

Rosann Tung, Ph.D., Genetics, 1997-1998

rtung (at) ccebos.org

Currently working in research and evaluation of urban school reform programs and initiatives. I work in an advocacy organization whose mission is to improve educational equity for low income students and students of color through transforming public schools and districts. http://www.ccebos.org

Lynn A. Cheatham, Ph.D., CDB, 1998-1999

lynn.cheatham (at) piedmontrc.com

After graduating, I worked for 3 years at Repligen Corporation, located in Waltham, MA, as a research scientist. I then moved to North Carolina and began working for a start-up biotech company, Amphora Discovery, involved in high-throughput screening of kinases involved in oncology. I now work for a CRO that offers in vivo and in vitro oncology related assays for pre-clinical drug development.

Susanna I. Chou, M.D./Ph.D., BCMP, 1998-1999

schou_md (at) trinity.westhost.com

Completed a family medicine residency and now have my own solo practice.

Saumya Das, M.D./Ph.D., Neuroscience, 1998-1999

sdas (at) partners.org

I finished my MD and did residency and general cardiology/cardiac arrhythmia fellowship at Massachusetts General Hospital. I am now an Instructor in Medicine, combining clinical cardiac electrophysiology with basic science.

Kathryn E. (Beauregard) Garber, Ph.D., Microbiology, 1998-1999

kgarbe2 (at) emory.edu

I was the Editorial Fellow for the American Journal of Human Genetics for 2 years after graduation before being promoted to Deputy Editor, a position I held until 2005. More recently, I have been serving as the Director of Education of the Dept. of Human Genetics at Emory University, which involves course development and teaching, especially of medical students.

Jorge L. Gonzalez, Ph.D., Neuroscience, 1998-1999

Jorge.Gonzalez (at) post.harvard.edu

Switched careers to computer programming and have worked in coporate application development ever since. Currently Chief Technology Officer at EF Education, Cambridge, MA.

Peter Juo, Ph.D., CDB, 1998-1999

Peter.Juo (at) tufts.edu

Current position: Assistant Professor, Tufts University, Boston, MA (2005-present)

Previous positions: Postdoc with Josh Kaplan (UC-Berkeley 2000-2002); Postdoc with Josh Kaplan (MGH/HMS 2002-2005)

Cheryl A. London, Ph.D., Immunology, 1998-1999

london.20 (at) osu.edu

Current position: Associate Professor, The Ohio State University, Columbus, Ohio: 2005-present

Previous position: Assistant Professor, University of California, Davis: 1999-2005

Jacqueline M. Slavik, Ph.D., Immunology, 1998-1999

jslavik (at) rics.bwh.harvard.edu

Current position: Administrative Director, Brigham and Women's Hospital, Boston, MA.

Previous positions: Postdoctoral Fellow (BWH), Instructor (BWH), and Program Manager, BRI (BWH)

Jamie M. Zeitzer, Ph.D., Neuroscience, 1998-1999

jzeitzer (at) stanford.edu

Current position: Assistant Professor, Stanford University, Palo Alto, CA.

Previous positions: 2-yr post doc in neurology at UCLA; 5-yr post doc in psychiatry at Stanford University

Heng Zhou, Ph.D., Genetics, 1998-1999

hzhou_2000 (at) yahoo.com

Current postion: Founder and CEO, Play! Int’l, Beijing, PR China.

Previous position: Consultant, McKinesy & Co.

Yun-Beom Choi, M.D./Ph.D., Neuroscience, 1999-2000

yc2029 (at) columbia.edu

Finished Harvard Medical School, 2000
Internship in internal medicine, Massachusetts General Hospital, 2001
Residency in neurology, Columbia-Presbyterian Medical Center, 2004
Post-doctoral fellow, Eric Kandel's laboratory, Columbia University Medical Center, present

Heather B. (Adkins) Huet, Ph.D., Virology, 1999-2000

heather.huet (at) biogenidec.com

After graduating in 2000, I came to Biogen for a 2 year post-doc working on TGFbeta/Activin pathway signaling in cancer. In 2002, I was hired as a scientist in the oncology research group, where I have worked on several early-stage drug development projects that focus on developing therapeutic antibodies to cell surface targets on cancer cells. Presently, I lead two research teams working to develop antibodies to receptor tyrosine kinase targets.

Dereth Renee Phillps, Ph.D., Genetics, 1999-2000

derethp (at) rice.edu

2000-2002: Postdoc in Arabidopsis signal transduction with Janet Braam. Lectureship in cell biology.

2003-present: Postdoc/research scientist in Arabidopsis biochemistry (triterpenoid biosynthesis) with Bonnie Bartel. Currently teaching and developing new courses as part of Bonnie Bartel's HHMI professor grant, Rice University, Houston, TX.

I am currently focusing on improving undergraduate science exposure for freshmen through development of interactive freshman seminar courses.

Lisa Monique Schechter, Ph.D., Microbiology, 1999-2000

schechterl (at) umsl.edu

Current position: Assistant Professor, University of Missouri, St. Louis.

Previous position: Post-doc at Cornell University.

Katie B. Shannon, Ph.D., CDB, 1999-2000

shannon (at) umr.edu

Current position: Assistant Professor, University of Missouri, Rolla.

Previous position: SPIRE post-doc (combination teaching and reasearch) at UNC Chapel Hill with Ted Salmon, 2000-2005.

Devyn M. Smith, Ph.D., Genetics, 1999-2000

devyn_smith (at) yahoo.com

7 years of strategy consulting. Currently focused on biopharm industry. Principal at The Frankel Group, Cambridge, MA.

Edward Jay Weinstein, Ph.D., Genetics, 1999-2000

edward.weinstein (at) sial.com

Current position: Manager of Operations in Functional Genomics at Sigma-Aldrich, St. Louis, MO.

Previous positions: Scientist in Oncology Pharmacology Department at Pfizer; Senior Scientist in Molecular Profiling Department at Merck